Compare E & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | E | IDXX |
|---|---|---|
| Founded | 1953 | 1983 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.0B | 57.1B |
| IPO Year | 1995 | 1991 |
| Metric | E | IDXX |
|---|---|---|
| Price | $39.41 | $697.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 10 |
| Target Price | N/A | ★ $700.50 |
| AVG Volume (30 Days) | 285.7K | ★ 435.7K |
| Earning Date | 02-26-2026 | 02-02-2026 |
| Dividend Yield | ★ 4.13% | N/A |
| EPS Growth | 6.01 | ★ 21.65 |
| EPS | 0.96 | ★ 12.60 |
| Revenue | ★ $101,555,790,226.00 | $4,167,411,000.00 |
| Revenue This Year | N/A | $12.15 |
| Revenue Next Year | N/A | $8.72 |
| P/E Ratio | ★ $19.12 | $54.84 |
| Revenue Growth | N/A | ★ 8.39 |
| 52 Week Low | $24.65 | $356.14 |
| 52 Week High | $39.41 | $769.98 |
| Indicator | E | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 61.09 | 48.64 |
| Support Level | $38.51 | $681.00 |
| Resistance Level | $39.00 | $709.24 |
| Average True Range (ATR) | 0.53 | 17.09 |
| MACD | 0.12 | -1.18 |
| Stochastic Oscillator | 98.20 | 51.26 |
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, the company produced 0.8 million barrels of liquids and 4.8 billion cubic feet of natural gas per day. At end-2024, Eni held reserves of 6.5 billion barrels of oil equivalent, 46% of which are liquids. The Italian government owns a 30.5% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity called Plenitude, which it will likely list publicly at some point.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.